| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.3M | +19.9% |
| Cost of Revenue | $57.4M | +14.5% |
| Gross Profit | $7.9M | +83.1% |
| R&D Expense | $519K | -2.6% |
| SG&A Expense | $15.6M | +33.1% |
| Operating Income | -$16.7M | -7.5% |
| Interest Expense | $1.9M | +87.7% |
| Pre-tax Income | -$19.1M | -18.3% |
| Income Tax | $0 | — |
| Net Income | -$19.1M | -18.3% |
| EPS (Basic) | -$0.63 | +46.2% |
| EPS (Diluted) | -$0.63 | +46.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $716K | +127.1% |
| Short-term Investments | $46K | +118.3% |
| Accounts Receivable | $19.6M | +45.6% |
| Inventory | $5.8M | +32.7% |
| Current Assets | $38.4M | +50.8% |
| Total Assets | $65.5M | +20.6% |
| Current Liabilities | $38.3M | +48.6% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | -9.5% |
| Capital Expenditures | $56K | -86.7% |
| Investing Cash Flow | -$2.0M | -152.4% |
| Financing Cash Flow | $14.1M | +178.5% |
| Free Cash Flow | -$8.5M | -4.5% |
| $3.8M |
| -8.1% |
| Total Liabilities | $47.1M | +58.0% |
| Stockholders' Equity | $18.4M | -24.9% |